Fedenia Advisers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Sell
1,122
-975
-46% -$203K 0.06% 112
2026
Q1
$443K Sell
2,097
-2,722
-56% -$586K 0.33% 52
2025
Q4
$990K Sell
4,819
-353
-7% -$66.4K 0.38% 63
2025
Q3
$812K Buy
5,172
+387
+8% +$59.8K 0.32% 72
2025
Q2
$804K Buy
4,785
+133
+3% +$19.7K 0.38% 63
2025
Q1
$641K Buy
4,652
+1,646
+55% +$210K 0.42% 43
2024
Q4
$356K Buy
+3,006
New +$351K 0.21% 94

Other funds holding CAH

Fedenia Advisers's CAH Position: Q2 2026 in Review

Fedenia Advisers reduced its Cardinal Health (CAH) stake by 46% in Q2 2026, selling an estimated $203K and leaving 1,122 shares worth $267K. The position accounts for 0.06% of the portfolio, ranked #112.

Fedenia Advisers first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $990K in Q4 2025. 412 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Fedenia Advisers held 1,122 shares of Cardinal Health worth $267K as of Q2 2026.
  • Fedenia Advisers sold 975 Cardinal Health shares in Q2 2026, an estimated $203K.
  • Cardinal Health made up 0.06% of Fedenia Advisers's portfolio in Q2 2026, its #112 holding.
  • Fedenia Advisers first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • Fedenia Advisers's Cardinal Health position peaked at $990K in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.